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Abstract
We evaluated effects of antiretroviral (ARV) therapy and lipid-based–nutrient-supplements (LNS) 
on iron, copper and zinc in milk of exclusively breastfeeding HIV-infected Malawian mothers, and 
their correlations with maternal and infant biomarkers. Human milk and blood at 2, 6, and 24wk 
postpartum and blood during pregnancy (≤30wk gestation) were collected from 535 mothers/
infant-pairs in the Breastfeeding, Antiretrovirals, and Nutrition (BAN) study. The participants 
received ARV, LNS, ARV and LNS, or no intervention from 0–28wk postpartum. ARVs negatively 
affected copper and zinc milk concentrations, but only at 2wk, while LNS had no effect. Among 
all treatment groups, approximately 80–90% of copper and zinc, and <50% of iron concentrations 
met the current Adequate Intake for infants at 2wk and only 1–19% at 24wk. Pregnancy 
hemoglobin was negatively correlated with milk iron at 2 and 6wk (r=−0.18, p<0.02 for both). The 
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associations of the milk minerals with each other were the strongest correlations observed 
(r=0.11–0.47, p<0.05 for all); none were found with infant biomarkers. At 2wk, moderately 
anemic women produced milk higher in iron when ferritin was higher or TfR lower. At 6wk, 
higher maternal AGP and CRP were associated with higher milk minerals in mildly anemic 
women. Infant TfR was lower when milk mineral concentrations were higher at 6wk and when 
mothers were moderately anemic during pregnancy. ARV affects copper and zinc milk 
concentrations in early lactation, and maternal hemoglobin during pregnancy and lactation could 
influence the association between milk minerals and maternal and infant iron status and 
biomarkers of inflammation.
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INTRODUCTION
Human milk is thought to ensure a balanced and adequate supply of nutrients to infants and 
is recommended by the World Health Organization (WHO) as the sole food source for the 
first six months of life (Brown et al. 2009; World Health Organization 2010). Maternal iron, 
copper, and zinc intake and status are assumed to have no effect on human milk minerals 
(Vuori et al. 1980; Moser et al. 1988; Picciano 2001; Domellöf et al. 2004; Mello-Neto et al. 
2014; Montalbetti et al. 2014); however, Krebs et al. (1985) reported that milk zinc 
concentrations are affected by maternal zinc intake within a physiological range and effects 
of low maternal intakes are most apparent with prolonged lactation. Even though the total 
concentration of iron, copper and zinc in human milk is low and decreases throughout 
lactation, their high bioavailability is assumed to ensure adequate supply during the first six 
months (Dorea 2000). Nevertheless, iron and zinc deficiencies in the perinatal period remain 
a public health concern, particularly in low-income countries, including Malawi (Gibson and 
Huddle 1998; Domellöf et al. 2004, National Statistical Office and ICF 2017), causing 
symptoms such as diarrhea, pneumonia, sub-optimal growth and development, normocytic 
hypochromic anemia, or even osteoporosis (Dauncey et al. 1977; Black et al. 2008).
In the context of maternal HIV-infection, breastfeeding is recommended for at least 12 
months, with continued breastfeeding up to 24 months while maternal antiretroviral (ARV) 
therapy is provided to reduce the risk of mother-to-child HIV-transmission (World Health 
Organization 2016). However, higher energy and nutrient requirements due to breastfeeding 
and HIV-infection might increase the risk of nutrient deficiencies for mother and infant (de 
Pee & Semba 2010; Kayira et al. 2012). Our previous research has shown that ARVs negate 
the positive effects of maternal LNS-consumption during lactation on B-vitamin 
concentrations in maternal serum and human milk (Flax et al. 2015; Allen et al. 2016). 
Negative ARV effects have also been reported on vitamin D and B12 status (Paltiel et al. 
1995; Woods et al. 2003; Childs et al. 2012). Thus, a potential impact of ARVs on iron, 
copper, and zinc concentrations in milk is possible and remains to be determined.
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We analyzed samples from a randomized controlled trial, in which lactating women were 
assigned to either ARV or lipid-based nutrient supplementation (LNS), ARV and LNS, or no 
intervention, to: a) examine the effects of ARV and LNS on iron, copper, and zinc 
concentrations in milk; b) compare the concentration of each mineral analyzed to the values 
that were used to set the Adequate Intake (AI) for infants 0–6 months (Institute of Medicine 
2001); c) assess correlations among the milk nutrients analyzed (iron, copper, zinc, fat); and 
d) examine relationships between milk minerals and maternal and infant characteristics, 
mineral and inflammation status using maternal and infant biomarkers.
METHODS AND MATERIALS
Participants and sample collection
The participants of the Breastfeeding, Antiretrovirals, and Nutrition (BAN) study included 
HIV-infected women recruited 2004–2009 from four antenatal clinics in Lilongwe, Malawi. 
Details of the recruitment and study design have been previously described (Ferguson et al. 
2009; van der Horst et al. 2009; Chasela et al. 2010; Kayira et al. 2012). Informed consent 
was obtained from all mothers. Based on the WHO guidelines at the time of the study, 
participants were encouraged to exclusively breastfeed for 24 weeks (wk) followed by rapid 
weaning from 24–28wk.
At delivery, mothers and their infants were randomized to a 2-arm (LNS, no-LNS) by 3-arm 
(maternal ARV, infant ARV, or neither) factorial design, which was condensed to four 
maternal intervention groups (Supplemental Figure 1). Infant ARV treatments were not 
considered as this report focuses on breast milk minerals and infant treatment would not 
influence human milk status. Since the LNS purposely included provision of energy and 
macronutrients, and micronutrients, neither participants nor physicians could be blinded to 
the study arm. Outcome assessors and sample and data analysts were blinded to the 
treatment allocation. The screening and enrollment process was conducted by the study 
nurses; a data manager produced the random distribution. The study pharmacist assigned the 
participants to the intervention using sequentially numbered envelopes and handed out ARV 
and LNS during the regular study visits at 0, 1, 2, 4, 6, 8, 12, 18, 21, 24, and 28wk 
postpartum. The women were instructed to consume two sachets of the LNS per day 
produced by Nutriset, France, www.nutriset.fr (Supplemental Table 1). The LNS provided 
0.3mg copper, 19mg zinc, and 15mg iron equivalent to 23, 158, and 168% of the U.S.-
Canada Recommended Dietary Allowances for copper, zinc, and iron respectively (Institute 
of Medicine 2001). The maternal ARV regimen consisted of zidovudine (300mg) and 
lamivudine (150mg) (Combivir®, GlaxoSmithKline) plus either nevirapine (until January 
2005), nelfinavir (January 2005-February 2006) or lopinavir (200mg) and ritonavir (50mg) 
(Kaletra; Abbott; February 2006 until study completion).
Reports of maternal LNS consumption were obtained at 1, 4, 8, 12, and 21wk. Maternal 
hemoglobin (Hb) was at assessed at ≤ 30wk gestation during the prenatal screening, and 
maternal and infant venous blood was collected at birth, 2, 6, 12, 18, and 24wk for further 
Hb measurements. Plasma for additional biomarker analysis was separated from red blood 
cells within 60min and stored at −70°C in 1mL aliquots. 10mL of human milk was collected 
during the regular study visits at 2 and 24wk (n=366), or 6 and 24wk (n=169) when a 2wk 
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milk or infant plasma sample was insufficient for micronutrient analysis. The milk was 
manually expressed by the study participant yielding an opportunistic sample that was 
immediately frozen after collection. The number of participants with available milk, 
maternal, and infant plasma samples pre-determined the sample size (n=535). Participants 
were preferentially selected if they provided anthropometry and dietary intake data. If the 
infants became HIV-positive or were multiple births, they were excluded from the sub-set. 
Details of the primary study’s sample size calculations have been previously described (van 
der Horst et al. 2009).
Samples were initially shipped on dry ice to the Centers for Disease Control and Prevention 
(CDC) in Atlanta and stored at −80°C until distribution to the USDA, ARS Western Human 
Nutrition Research Center (WHNRC) in Davis, CA for analysis.
Biochemical Analyses
Iron, copper, and zinc were analyzed in 500µL of whole human milk. 150µL of the 1.00ppm 
calibration standard in nitric acid (HNO3, 3.2N, for trace analysis), 2.25mL HNO3 (3.2N) 
and 100µL peroxide (for trace analysis) were added to a final volume of 3.0mL. Samples 
were mixed and microwaved for 15min at 90°C (600 watts, 5min ramp from ambient 
temperature to 90°C, temperature controlled). After a 5min cooling step the samples were 
centrifuged for 10min at 2750 × g (4°C) after which they were transferred into the 8mL 
polypropylene tubes (13 × 100mm, Perfector Scientific, Fair Lawn, NJ, USA) for analysis or 
capped and stored at 4°C until analysis. The laboratory internal control (BLS) and the 
0.2ppm standard, analyzed with each sample set, revealed an inter-assay variation of 1.5 – 
7.0% and an intra-assay variation of 0.1–10.8% over a period of 6wk (n=25). The calibration 
curve for each mineral consisted of a blank and ten standard solutions in a linear range of 
0.0125 – 2.000ppm prepared in 3.2N HNO3. Due to the difference in concentration of each 
analyte in human milk, the actual standard concentrations used for each mineral were as 
follows: Cu: 0.0125–1.000ppm, Fe: 0.025–1.000ppm, and Zn: 0.0125–2.000ppm. Mean 
recovery rates for copper, iron, and zinc were 92.6 ±5.7%, 89.4 ±7.2% and 94.7 ± 6.8% 
respectively. The analyses were conducted using a Varian VISTA AX CCD Simultaneous 
ICP-AES (Folsom, CA, USA) operated by ICPExpert software. Samples were digested 
using the CEM Microwave Accelerated Reaction System (MARS 5; Matthews, NC, USA). 
The milk fat was measured using the Creamatocrit Plus (Medela, McHenry, IL, USA) 
according to the manufacturer’s protocol. The tube reader’s accuracy was validated using the 
Medela control strip.
The inflammatory markers α-1-acid glycoprotein (AGP) and C-reactive protein (CRP), and 
soluble transferrin receptors (TfR) in maternal and infant plasma were analyzed by a 
COBAS® Integra 400 Plus multianalyte-analyzer (Roche Diagnostics, Mannheim, 
Germany). Ferritin concentrations were determined using IRMA Ferritin Coat-a-Count 
radioimmunoassay (Siemens Health Care Diagnostics, Tarrytown, NY, USA), and Hb was 
measured using the AcT or AcT 5-part Differential Analyzer (Beckman Coulter, Fullerton, 
CA, USA).
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Ethics
This research was approved by the Malawian National Health Science Research Committee, 
the Institutional Review Boards at the University of North Carolina at Chapel Hill, the U.S. 
Centers for Disease Control and Prevention, and the University of California, Davis (Clinical 
Trials.gov; NCT00164762). The trial was monitored for safety and efficacy by the National 
Institute of Allergy and Infectious Diseases Vaccine and Prevention Data and Safety 
Monitoring Board.
Statistical Methods
Since milk sample collection started 2 to 6wk after the LNS intervention, no true baseline 
concentrations were available for statistical analyses (Allen et al. 2016). A separate binary 
variable, hereafter referred to FTP (first time point), was used to control for whether the first 
time point of sample collection occurred at 2wk (FTP2) or 6wk (FTP6). The outcomes were 
concentrations of iron, copper, and zinc in human milk, within the 4 defined groups (ARV, 
LNS, ARV/LNS, and control). SAS® for Windows Release 9.4 (SAS Institute, Cary, NC, 
USA) was used for all statistical analyses. Square root transformations were performed on 
all outcome variables to normalize the distributions. The original hypothesis focused on the 
effect of LNS supplementation on outcomes. However, preliminary data revealed significant 
effects due to ARV for some of the minerals so the hypothesis was modified to include 
possible main effects and modifying effects of ARV. Mixed models repeated measures 
analysis of variance was used to fit a 4-factor model, which included LNS, ARV, and FTP as 
between-subject main effects, time as a within-subject main effect, all 2-, 3-, and 4-factor 
interactions, and a random effect of subject assuming an unstructured covariance matrix. 
When there was no significant interaction between treatment and FTP, treatment was 
assessed as a main effect only.
All analyses described in this paragraph were conducted using pooled milk values for each 
mineral from all treatment groups. Iron, copper and zinc milk concentrations were 
significantly lower at 6wk than at 2wk; thus, to estimate the correlations of the breast milk 
iron, copper, and zinc concentrations with maternal and infant biomarkers and 
characteristics, we analyzed the data separately by FTP (2 or 6wk) subgroup. Pearson 
correlations procedure was used. Concentrations of maternal ferritin, maternal CRP, 
maternal TfR, infant ferritin, infant CRP, infant AGP, and maternal age were log-
transformed; infant TfR and birthweight were square-root transformed, and maternal AGP, 
body mass index (BMI), and infant Hb were inverted (1/x) to achieve normal distributions. 
Inverted variables were multiplied by −1 to preserve direction. Pregnancy Hb, maternal Hb 
and infant birth length were normally distributed and not transformed. Spearman 
correlations were used to explore relationships of breast milk iron, copper, and zinc 
concentrations with non-normalized maternal and infant characteristics including marital 
status, literacy, education, parity, famine season (August to March), and infant sex. Linear 
regression analysis was used to examine associations a) between maternal iron status 
(ferritin, TfR) and inflammation (AGP, CRP) biomarkers on human milk iron, copper, and 
zinc at 2, 6, and 24wk, stratified by anemia status during pregnancy (non-anemic: Hb ≥ 
110g/L, mildly anemic: Hb 100–109g/L, moderately anemic: Hb 70–99g/L, severely 
anemic: Hb ≤ 70g/L) and lactation (non-anemic: Hb ≥ 120g/L, mildly anemic: Hb 110–
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119g/L, moderately anemic: Hb 80–109g/L, severely anemic: Hb ≤ 80g/L) (World Health 
Organization 2011) and b) between maternal iron status biomarkers (ferritin, TfR, Hb, 
pregnancy Hb) on human milk iron, copper, and zinc at 2, 6, and 24wk, stratified by 
inflammation status (AGP > 1g/L and CRP > 5mg/L).
For all procedures, p-values <0.05 were considered to be statistically significant. Significant 
differences in the distribution of categorical variables were examined using the chi-square 
test. Significant changes in milk adequacy (based on AI) over time (2, 6, 24wk) were tested 
using the GLIMMIX procedure.
The measured human milk iron, copper, and zinc concentrations at each time point (TP), 
FTP of milk collection and treatment group were also compared to milk values from well-
nourished women used by the Institute of Medicine to set Adequate Intakes (AIs) for infants 
from 0–6mo of age (Institute of Medicine 2001).
RESULTS
Maternal characteristics at first time point
The characteristics of the participants were similar among treatment groups at the FTP of 
human milk collection (Table 1). Significant differences were only observed for the CD4 
counts with higher counts for the groups that received ARV. The median BMI was within the 
normal range and the overall compliance with supplementation and ARV treatment was 
high. In the adherence reports collected over five follow-up visits the mothers self-reported 
that they took their prescribed ARV treatment 89% of the time and LNS supplement 92% of 
the time. The self-reported frequency of exclusive breastfeeding was 96% at 21wk 
postpartum (Chasela et al. 2010; Kayira et al. 2012).
Treatment effects and time interactions
The mixed model analysis revealed that the concentrations of the three minerals changed 
over time (TP) and differed by FTP (p<0.02 for all). For iron, no interactions by treatment 
(ARV and LNS) or with treatment and TP and/or FTP were significant indicating that the 
effects of ARV and LNS at 2, 6, and 24 wk were not different from each other 
(Supplemental Table 2). Therefore, pooled data for all treatment groups and all time points 
combined were used for further statistical analyses involving iron. ARV by TP by FTP 
interactions were significant for copper (p=0.034), while ARV by FTP interactions were 
significant for zinc (p=0.031). Thus, to evaluate the main effects, samples from 2, 6, and 
24wk were analyzed separately for copper and zinc.
The reduction in milk iron concentrations between 2, 6 and 24wk was independent of 
treatment. ARV by LNS interactions were not significant for any of the minerals analyzed 
nor were LNS and ARV main effects significant for iron (Table 2). The mixed model 
analysis for copper and zinc at 2, 6, and 24wk showed that ARV treatment significantly and 
negatively affected milk copper and zinc concentrations (p=0.044 and p=0.014) but only at 
the initial 2wk time point.
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Comparison of milk iron, copper, and zinc concentrations with values used to set the 
Adequate Intake (AI) for infants 0–6mo
At 2wk, 38–48% of all milk samples met the milk iron concentrations assumed from 
reported data used to estimate the AI for infants from 0–6mo (Table 3). Depending on 
treatment group approximately 89–94% and 78–88% of the samples had copper and zinc 
concentrations at 2wk that corresponded to AI values (Institute of Medicine 2001).
Lower breast milk iron, copper, and zinc concentrations were observed at 6wk: 27–35% of 
the milk samples met the AI for iron concentrations, 39–61% and 40–47% the AI for copper 
and zinc concentrations.
At 24wk only about 11–19% of all samples met the AI estimates for iron. Copper and zinc 
concentrations were even lower; only 5–9% (copper) and 1–4% (zinc) of the samples met 
the AI concentrations. Plotting the relative amount of samples that met the AI longitudinally 
by FTP subgroup (2–24 and 6–24wk), copper and zinc followed the same pattern of 
decrease, while the iron AI was met by considerably fewer samples compared to the copper 
and zinc already at 2wk, but then followed a slower rate of decrease (Figure 1).
Correlations of maternal and infant biomarkers and characteristics with breast milk 
minerals
Iron, 2 and 6wk—At 2wk, human milk iron concentrations were significantly correlated 
with pregnancy Hb (r = −0.18, p<0.001) and parity (r = −0.11, p=0.031) as well as with 
breast milk copper (r = 0.29, p<0.001), zinc (r = 0.11, p=0.028), and fat (r = 0.11, p=0.044; 
Figure 2). At 6wk, breast milk iron was correlated with pregnancy Hb (r = −0.18, p=0.019), 
maternal AGP (r = −0.25, p=0.001), and breast milk copper (r = 0.47, p<0.001) and fat (r = 
0.24, p=0.002).
Copper, 2 and 6wk—At 2wk, human milk copper concentrations were correlated with 
maternal AGP (r = 0.12, p=0.021) and CRP (r = −0.19, p<0.001), and milk iron, zinc (r = 
0.36, p<0.001), and fat (r = 0.13, p=0.01) (Figure 2). At 6wk, milk copper was also 
correlated with pregnancy Hb (r = −0.15, p=0.047), maternal AGP (r = −0.15, p=0.049) and 
breast milk iron and zinc (r = 0.28, p<0.001).
Zinc, 2 and 6wk—At 2wk, milk zinc concentrations were significantly correlated only 
with milk iron and copper. At 6wk, human milk zinc was correlated with maternal AGP (r = 
−0.17, p=0.03) and breast milk copper.
Iron, copper, and zinc, 24wk—At 24wk, neither iron nor copper concentrations were 
correlated with any of the maternal or infant biomarkers (Figure 2). Only zinc showed a 
correlation with maternal BMI (r = 0.12, p=0.006). Significant correlations remained 
between the analyzed human milk minerals and fat: iron was correlated with copper (r = 
0.31, p<0.001) and fat (r = 0.22, p<0.001), and copper with zinc (r = 0.11, p < 0.001) and fat 
(r = 0.21, p<0.001), additionally, zinc was correlated with fat (r = 0.13, p=0.003).
None of the infant biomarkers or characteristics were significantly associated with human 
milk iron, copper, or zinc concentrations at any time point.
Hampel et al. Page 7
Matern Child Nutr. Author manuscript; available in PMC 2019 February 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Associations of human milk iron, copper and zinc with maternal and infant biomarkers, 
stratified by maternal Hb (anemia status) during pregnancy and lactation
Maternal Biomarkers
2wk: When women were moderately anemic postpartum, higher ferritin during lactation was 
associated with higher human milk iron concentrations when compared to mildly anemic 
(p=0.017) and non-anemic (p=0.037, Figure 3) pregnant women, while higher TfR in 
lactation was associated with lower milk iron compared to the non-anemic group (p=0.024). 
Additionally, higher maternal CRP during lactation was associated with lower milk copper 
compared to that of non-anemic women (p=0.016). The degree of anemia in pregnancy did 
not affect the relationship of the maternal biomarkers to milk zinc concentrations (data not 
shown). When women were moderately anemic during pregnancy, higher TfR 
concentrations postpartum were associated with lower milk iron concentrations compared to 
those of non-anemic women (p=0.030).
6wk: In women who were mildly anemic during lactation, higher CRP postpartum was 
associated with higher milk iron (p=0.013) and copper (p=0.036) compared to non-anemic 
women, while higher AGP was associated with higher milk iron (p=0.002), and zinc 
(p=0.002) concentrations. Higher AGP was associated with lower copper concentrations 
when comparing moderately anemic postpartum women to mildly-anemic women 
(p=0.004), yet higher AGP was associated with higher copper when comparing mildly 
anemic to non-anemic postpartum women (p=0.005). When women were moderately 
anemic during pregnancy, higher postpartum AGP concentrations at 6wk were associated 
with higher milk iron concentrations compared to concentrations in non-anemic women 
(p=0.027).
24wk: Higher maternal TfR concentrations at 24wk were associated with lower milk iron 
values in moderately (p=0.008) and mildly (p=0.009) anemic women compared to non-
anemic participants at 24wk.
Infant biomarkers
2wk: Higher milk copper was associated with lower AGP at 2wk among infants of mothers 
who were mildly anemic during lactation, compared to infants of mothers who were not 
anemic, (p=0.037) (Figure 4). For those infants whose mothers were moderately anemic 
during pregnancy, higher milk zinc was associated with higher infant TfR concentrations 
compared to infants born to women who were not anemic during pregnancy (p=0.037).
6wk: When the women had been mildly anemic during lactation, higher milk iron 
concentrations were associated with lower infant ferritin (p=0.018) compared to infants born 
to non-anemic women. When mothers were moderately anemic during pregnancy, higher 
milk iron, copper, and zinc concentrations were associated with lower infant TfR compared 
to women whom were not anemic (piron=0.004, pcopper=0.016, pzinc=0.018). When women 
were mildly anemic during pregnancy, higher milk iron and copper were associated with 
lower infant AGP at 6wk compared to non-anemic women during pregnancy (piron=0.041, 
pcopper=0.043).
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24wk: When mothers were moderately anemic, increasing copper in milk was associated 
with increasing infant CRP when compared to mildly (p=0.046) and non-anemic (p=0.009) 
women.
Human milk iron, copper and zinc concentrations and inflammation
In the pooled samples set (n = 1074), iron, copper, and zinc concentrations in the milk of 
HIV-infected Malawian mothers were significantly higher (p<0.001 for all; Table 4) in 
women with evidence of inflammation (AGP > 1g/L, CRP > 5mg/L). Moreover, women 
with inflammation revealed higher milk iron concentrations at 2wk when their pregnancy Hb 
status was lower (p = 0.015; no inflammation (coeff. (std error): −0.012 (0.010), 
inflammation: −0.050 (0.013)), and showed higher milk zinc concentrations at 6wk when 
their pregnancy Hb status was higher (p = 0.020; no inflammation (coeff. (std error): −0.032 
(0.022), inflammation: 0.091 (0.047)).
DISCUSSION
The recommendation to exclusively breast feed for the first 6mo of life demands an 
understanding of how maternal micronutrient supplementation and drugs, such as ARVs, 
affect human milk nutrient concentrations. LNS are commonly used to treat severe acute 
malnutrition in children; their effectiveness in improving birth and health outcomes in 
infants and children with moderate malnutrition and their effectiveness in prevention of 
stunting has also been under evaluation (Phuka et al. 2010; Thakwalakwa et al. 2010; Adu-
Afarwuah et al. 2015, Prado et al., 2016). In the BAN study, maternal LNS mitigated 
maternal weight-loss even when ARVs were given (Kayira et al. 2012) and increased human 
milk B-vitamin concentrations, while ARVs negatively affected some B-vitamins. When 
ARV and LNS were given, ARV diminished the positive LNS effect (Allen et al. 2016). 
However, beneficial effects of maternal supplemetation or fortification on human milk B-
vitamins have been also observed in other studies (Duggan et al. 2014; Shahab-Ferdows et 
al. 2015; Siddiqua et al. 2015; Whitfield et al. 2016).
Treatment effects
Human milk iron, copper, and zinc concentrations are thought to be unaffected by maternal 
supplementation (Vuori et al. 1980; Moser et al. 1988; Picciano 2001; Domellöf et al. 2004; 
Montalbetti et al. 2014), which is consistent with our results. Maternal ARV treatment, 
however, negatively affected milk copper and zinc concentrations at 2wk, resulting in a 5–
8% reduction of the median copper and zinc concentration available to the infant. These 
reduced amounts might not be significant to a healthy infant but could impact infants 
exposed to nutritional deficiencies as they do not possess extensive zinc or copper stores. 
Moreover, maternal ARV treatment in this study was reflected in the milk and lamivudine 
was found in infant plasma (Shapiro et al. 2005; Corbett et al. 2014), observations 
particularly important in light of the 2016 WHO guidelines that recommend ARV provision 
to HIV-infected mothers of HIV-exposed infants. Certain ARVs provided to the mother are 
transmissible through human milk, which could impact the infants’ ability to fight a possible 
HIV infection (Zeh et al. 2011). Thus, maternal ARVs are not only transferring to the infant 
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through human milk but also, in our study, affect the transfer of zinc and copper during early 
lactation, and possibly other nutrients, into milk and subsequently to the infant.
The milk mineral concentrations from these HIV-infected mothers were comparable to other 
reported values from healthy women in the USA, Iran, and Brazil (Picciano & Guthrie 1976; 
Mahdavi et al. 2010; Mello-Neto et al. 2013). Thus, maternal HIV status might not or only 
marginally affect milk mineral concentrations. However, another study conducted in the 
USA revealed considerably higher mineral concentrations in milk from apparently healthy 
mothers (Feeley et al. 1983), while women in Vietnam produced milk with higher iron and 
copper but lower zinc concentrations at 6mo postpartum (Nakamori et al. 2009).
Comparison of milk iron, copper, and zinc concentrations with values used to set the 
Adequate Intake (AI) for infants 0–6mo
Despite the negative ARV effect on breast milk copper and zinc concentrations, 89–94% and 
78–81% respectively of the milk samples obtained at 2wk met the concentrations used to set 
the AI for infants. When no ARVs were provided, 88% of the samples reached adequate zinc 
concentrations at 2wk versus 78–81% when ARV were taken, reiterating the already noted 
negative influence of ARV on zinc levels in breast milk at early stages of lactation. Only 38–
48% of the iron concentrations at 2wk met AI values. However, the naturally occurring 
decrease in concentrations during lactation (Lönnerdal et al. 1981a; Silvestre et al. 2001; 
Brown et al. 2009) was lower for iron than for copper and zinc, suggesting mineral-specific 
kinetic rates of transport and secretion into milk. Iron, copper, and zinc concentrations in 
milk are at their peak during the first few days postpartum and decrease as lactation 
progresses. However, the concentrations of these trace minerals are remarkably stable at all 
lactation stages as they are tightly regulated and maintained by the mammary epithelial cells 
(Montalbetti et al. 2014).
Infants possess extensive iron stores in the liver that offset the low milk levels and ensure 
adequate supply. Due to the extreme changes in concentrations of minerals in milk within 
the first 6mo postpartum, a range of AI values would be more accurate for estimating 
adequate intake than the current single value approach; the natural decrease in concentration 
will result in theoretically insufficient concentrations of these minerals in breast milk, even 
though the infant may actually be adequately supplied. Moreover, the AI values for these 
trace minerals are based on limited data (9–15 studies with low numbers of participants) 
(Institute of Medicine 2001). Thus, the concentrations of iron, copper, and zinc measured in 
our study cannot be interpreted as insufficient based solely on the current AI-estimates. 
Longitudinal data from big data sets such as the BAN study provide important additional 
information for the assessment of milk mineral content.
Correlations of maternal and infant biomarkers and characteristics with human milk 
minerals
In the BAN study, changes in maternal TfR and Hb were associated with those observed in 
infant TfR and Hb (Widen et al. 2014). However, neither of these maternal or infant iron 
status biomarkers showed a significant correlation with milk iron, copper, or zinc, indicating 
that the breast milk minerals are not the determining factor for infant iron (TfR, ferritin, Hb) 
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status during lactation. In fact, Mahdavi et al. (2010) showed that milk iron, copper, and zinc 
concentrations and the infant’s weight for age and height for age Z-score are not 
significantly associated, and Murray et al. (1978) reported no significant differences between 
milk iron and infant iron status measures, showing the independence of infant outcomes 
from human milk mineral concentrations.
Interestingly, we found that women with lower Hb during pregnancy (≤30wk gestation) 
produced milk with higher iron concentrations at both 2 and 6wk, while none of the 
postpartum maternal iron status biomarkers (Hb, ferritin, TfR) were associated with milk 
minerals at these time points, suggesting that maternal iron status during pregnancy may 
affect milk iron concentrations during early stages of lactation. Using BeWo cell layers as a 
model for placental iron transfer in rats fed decreasing iron levels Gambling et al. (2001) 
found increased mRNA and protein expression of TfR and of the divalent metal 
transporter-1 (DMT-1). Recently, Jobarteh et al. (2017) confirmed an up-regulation of 
mRNA of placental TfR1 in Gambian women with low iron status; this increase might 
represent a mechanism to ensure fetal requirements are met. Such alterations in iron 
metabolism could also occur in the mammary epithelial cells that regulate mineral secretion 
into milk, which also involves TfR- and DMT1-regulated processes (Montalbetti et al. 
2014). Given that this relationship was observed in two independent groups and time of 
pregnancy during screening did not affect Hb status (data not shown), this consistent 
significant and negative association between pregnancy Hb and human milk iron deserves 
further investigation. Parity and maternal BMI were the only characteristics associated with 
breast milk minerals; while parity and iron concentrations were correlated at 2 wk, maternal 
BMI and zinc concentrations were correlated at 24wk. These findings indicate that higher 
parity could adversely affect iron, while higher BMI might positively influence breast milk 
zinc concentration during later stages of lactation.
The strongest correlations (all positive) were found among the human milk minerals. All of 
them were also associated with the milk fat, an observation previously described by Finley et 
al. (1985). Given that all three minerals are partly present in the lipid fraction of the milk 
(Fransson & Lönnerdal 1980, 1982, 1984; Lönnerdal et al. 1982; Donangelo et al. 1989; 
Hiari et al. 1990; Wooten et al. 1996; Linder et al. 1998), the correlation with milk fat is not 
unexpected. Copper and zinc are both bound to serum albumin, casein, and citrate in milk 
(Lönnerdal et al. 1982); their positive association suggests that the two minerals are not 
competing for the same binding site but rather for the availability of additional binding 
capacity (Finley et al. 1985; Lönnerdal et al. 1981b). Positive correlations between milk iron 
and copper have also been reported by Feely et al. (1983), concluding that milk from 
mothers with high amounts of iron may also be more likely to contain high concentrations of 
copper. Given the intertwined relationships of mineral metabolism (Institute of Medicine 
2001), the close association of their concentrations in milk is not surprising.
Associations of human milk iron, copper and zinc with maternal and infant biomarkers, 
stratified by maternal Hb (anemia status) during pregnancy and postpartum
Limited research has focused on the relationship of maternal and infant iron status 
biomarkers with breast milk mineral content. Kumar et al. (2008) showed that severe 
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maternal anemia adversely affected cord blood and human milk iron concentrations. In our 
study, moderately anemic women with higher ferritin also had a higher concentration of iron 
in their milk compared to non-anemic or only mildly anemic women at 2wk, while lower 
TfR was associated with higher milk iron content in moderately anemic compared to non-
anemic women at 2 and 24wk. Although iron secretion is tightly regulated and maintained 
by the mammary epithelial cells, little is known about the molecular and cellular 
mechanisms regulating mineral concentrations in the milk (Montalbetti et al. 2014). Thus, 
while milk iron concentrations are assumed to be independent from maternal intake, our 
observations indicate the possibility of a less understood yet complex relationship on the 
molecular and cellular level between maternal iron status during pregnancy and the amounts 
of iron in milk during early lactation.
At 6wk, mildly anemic women with higher concentrations of the inflammation biomarkers 
AGP and CRP also had higher concentrations of iron, copper and zinc in their milk than 
women with normal Hb. Based on the categories of inflammation proposed by Thurnham et 
al. (2008), about 23% of the mildly anemic women at 6wk showed early stages of infection 
or convalescence. After adjusting for inflammation the described relationships persisted, 
suggesting that the association of maternal AGP/CRP and milk minerals in mildly anemic 
women is not directly caused by inflammation (Supplemental Table 5).
The degree of maternal anemia during pregnancy or lactation may also affect the 
relationship between breast milk minerals and infant biomarkers. We found that infants from 
mildly anemic mothers at 2wk, who secrete more copper into milk, have lower AGP 
concentrations, an effect also found for breast milk iron and copper at 6wk for women who 
were mildly anemic during pregnancy. Infant TfR also seemed to be affected by maternal Hb 
status and was lower when breast milk iron, copper and zinc were higher, but only when 
comparing moderately-anemic to non-anemic mothers. To our knowledge, no previous 
reports have investigated these associations.
These relationships between milk minerals and infant status may be linked to maternal 
anemia status. Alterations in maternal mineral metabolism related to maternal iron status 
have been recently described (Jobarteh et al. 2017); however, more research is necessary to 
understand any influence of this effect on infant status.
Human milk iron, copper and zinc concentrations and inflammation
Information is sparse regarding the impact of inflammation on breast milk minerals. 
However, effects of inflammation on maternal status may indirectly affect breast milk 
mineral concentrations. Inflammation has been associated with reduced iron incorporation 
into heme, and increased blood copper, and decreased zinc concentrations (Aggett & Harries 
1979; Beshgetoor & Hambidge 1998; van den Broek & Letsky 2000). The leucocyte 
endogenous mediator (LEM) is thought to be involved by enhancing the hepatic uptake of 
zinc and iron, and by synthesis of acute phase proteins such as ceruloplasmin, a multi-
copper ferrioxidase (Gambling et al. 2008). Recent findings describe an up-regulation of 
placental iron and zinc transporters in Gambian women with low iron and zinc status 
(Jobarteh et al. 2017), proteins also located in the mammary gland (McCormick et al. 2014; 
Montalbetti et al. 2014). These alterations in mineral metabolism could extend into milk 
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secretion, e.g. due to a signaling cascade. Our findings of higher milk iron, copper, and zinc 
concentrations in women with inflammation indicate higher influx of these minerals into 
milk when inflammation occurs. Moreover, the inflammation-related higher milk iron 
concentrations at 2wk when the woman’s pregnancy Hb status was lower, and higher milk 
zinc concentrations at 6wk when their pregnancy Hb status was higher, support a potential 
up-regulated iron and zinc secretion into milk when women were subjected to health 
challenges such as low status and inflammation. Interestingly, no such relationships were 
found with Hb status during lactation, indicating that pregnancy Hb status might have a 
stronger impact than Hb status during lactation. However, Broek and Letsky (2000) also 
found an independent effect of HIV-infection on Hb concentrations that was not associated 
with concurrent infection or dietary deficiencies. Thus, the extent of the interrelationships of 
inflammation, pregnancy Hb and milk mineral concentrations has yet to be determined.
Limitations and Conclusions
Despite the extensive number of milk samples analyzed in the BAN study, the samples 
collected are opportunistic and may not reflect a 24h milk sample. Moreover, our initial 
samples were collected 2 and 6wk into the intervention, thus not reflecting a true baseline. 
The low dose of copper in the LNS (only 23% of the RDA) may also be insufficient to detect 
a difference in milk copper concentrations. Exploring the data for associations based on 
maternal Hb status resulted in a few sub-groups with small sample sizes (e.g., n=13 or 16, 
Figures 3 and 4; Supplemental Tables 3 and 4) which may not be generalizable to the larger 
population. However, unique characteristics of the study include longitudinal collection of 
breast milk in a relatively large sample of women, high adherence to recommendations to 
exclusively breastfeed, and the randomized control design, which enabled analysis of the 
effects of LNS and ARV, and their interactions, on milk micronutrients. ARV affected milk 
copper and zinc concentrations and was not offset by maternal supplementation during 
lactation. Even though this negative effect appears to be limited and only at early lactation, 
the extent of the impact on the infant has yet to be determined as well as possible remedies. 
Although we found significant correlations between maternal biomarkers and characteristics 
with milk minerals, those correlations were weak and further studies are required to gain 
better insight into the complex relationships between maternal and infant biomarkers and 
breast milk mineral concentrations.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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KEY MESSAGE
• Maternal supplementation with lipid-based nutrient supplements during 
lactation had no effect on iron, copper, and zinc concentration in human milk.
• Maternal antiretroviral therapy negatively affected copper and zinc 
concentration in human milk in early lactation.
• Milk mineral concentrations quickly decreased during lactation with less than 
50% of samples with adequate iron concentrations at 2wk.
• The strongest correlations throughout lactation were found among the milk 
minerals, and milk fat.
• Maternal Hb during pregnancy or lactation could influence the relationship 
between milk minerals and maternal and infant biomarkers for inflammation 
and iron stores.
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Figure 1. 
Relative median decrease [%] in human milk iron, copper, and zinc over time compared to 
AI (values pooled from all treatment groups at each time point of sample collection: A – 
FTP2 subgroup (2–24wk; n = 366); B – FTP6 subgroup (6–24wk; n = 169).
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Figure 2. 
Significant correlations between milk minerals and maternal biomarkers at 2, 6, and 24 wk. 
Pearson’s correlation coefficients (Spearman correlations coefficient for the characteristics) 
are shown and level of significance as: * p < 0.05; ** p < 0.01; *** p < 0.001 (Preg.- 
pregnancy (during screening), Hb – hemoglobin, BM - breast milk, Fe - iron, Cu – copper, 
Zn – zinc, Mat. – maternal, AGP - α-1-acid glycoprotein, CRP - C-reactive protein, BMI - 
body mass index).
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Figure 3. 
Associations of human milk iron, copper, and zinc with maternal biomarkers stratified by 
maternal hemoglobin status during pregnancy and lactation on (Coefficients and SEs 
obtained from regression procedure displayed as bar graphs with error bars. P-values for 
comparisons of moderately or mildly anemic to non-anemic group, and comparison of 
moderately to mildly anemic group, using linear regression analysis. Anemia, state of 
anemia - moderately, mildly, or non-anemic - based on maternal hemoglobin status at 
indicated week postpartum (World Health Organization 2003). AnemiaPreg, state of anemia 
during pregnancy (moderately, mildly, or non-anemic based on maternal Hb during 
pregnancy, World Health Organization, 2003). BM – breast milk, CRP - C-reactive protein, 
AGP - α-1-acid glycoprotein, TfR - soluble transferrin receptors; n - number of samples 
(moderatly anemic/mildly anemic/non-anemic): 2wk anemia: 41/49/276; 2wk anemiaPreg: 
91/106/169; 6wk anemia: 13/25/131; 6wk anemiaPreg: 35/53/81; 24wk anemia: 16/45/476; 
24wk anemiaPreg: 126/160/251; Separate models were used for each time point and FTP and 
anemia status).
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Figure 4. 
Associations of human milk iron, copper, and zinc with infant biomarkers stratified by 
maternal hemoglobin status during pregnancy and lactation (Coefficients and SEs obtained 
from regression procedure displayed as bar graphs with error bars). P-values for 
comparisons of moderately or mildly anemic to non-anemic group, and comparison of 
moderately to mildly anemic group, using linear regression analysis. Anemia, state of 
anemia - moderately, mildly, or non-anemic - based on maternal hemoglobin status at 
indicated week postpartum (World Health Organization 2003). AnemiaPreg, state of anemia 
during pregnancy (moderately, mildly, or non-anemic based on maternal Hb during 
pregnancy, World Health Organization, 2003). BM – breast milk, CRP - C-reactive protein, 
AGP - α-1-acid glycoprotein, TfR - soluble transferrin receptors, n - number of samples 
(moderatly anemic/mildly anemic/non-anemic): 2wk anemia: 41/49/276; 2wk anemiaPreg: 
91/106/169; 6wk anemia: 13/25/131; 6wk anemiaPreg: 35/53/81; 24wk anemia: 16/45/476; 
24wk anemiaPreg: 126/160/251; Separate models were used for each time point and FTP and 
anemia status).
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Table 4
Median concentrations and interquartile ranges (IQR) of the pooled samples (all TP and FTP) of iron, copper, 
and zinc in breast milk of HIV-infected Malawian mothers in the BAN Study based on inflammation status1
Mineral No inflammation Inflammation
n 835 239
Iron
Median, mg/L 0.224 0.325
IQR, mg/L 0.140–0.342 0.212–0.456
p-valuea < 0.001
Copper
Median, mg/L 0.196 0.291
IQR, mg/L 0.129–0.319 0.192–0.375
p-value < 0.001
Zinc
Median, mg/L 1.75 2.90
IQR, mg/L 0.988–2.93 1.69–3.74
p-value < 0.001
1
Inflammation defined as AGP > 1g/L and CRP > 5mg/L.
a
P-values obtained from general linear models.
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